Xconomy Boston

NKT Therapeutics, Inc. Obtains $8,000,000 Series A Financing Round

  • Feed Type
  • Date
    3/16/2009
  • Company Name
    NKT Therapeutics, Inc.
  • Mailing Address
    233 Needham Street Newton, MA 02464
  • Company Description
    NKT Therapeutics, Inc. (the Company) is a biotechnology company focused on developing therapeutics based on unique immune cells called natural killer T (NKT) cells. NKT cells are a rare but central component of the human immune system which plays a pivotal role in human health and disease.
  • Website
    http://www.nktrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    SV Life Sciences
  • Venture Investor
    MedImmune Ventures

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.